Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionguanyl-nucleotide exchange factor activity

DENND6A ABR MCF2L2 ARFGEF2 DENND1C HERC1

9.62e-05231646GO:0005085
GeneOntologyMolecularFunctionnucleoside-triphosphatase regulator activity

DENND6A TBC1D4 ABR MCF2L2 ARFGEF2 DENND1C HERC1 RASAL1

2.08e-04507648GO:0060589
GeneOntologyMolecularFunctionGTPase regulator activity

DENND6A TBC1D4 ABR MCF2L2 ARFGEF2 DENND1C HERC1 RASAL1

2.08e-04507648GO:0030695
GeneOntologyMolecularFunctionoxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor

SELENBP1 QSOX2

5.46e-0411642GO:0016670
GeneOntologyMolecularFunctionvinculin binding

DMD UTRN

7.71e-0413642GO:0017166
GeneOntologyMolecularFunctioncGMP binding

CNGB1 PDE11A

1.18e-0316642GO:0030553
DomainARM-type_fold

MON2 CAND2 MROH2A LTN1 ARFGEF2 CUL9 HEATR1 UNC79 XPO7

1.67e-06339629IPR016024
DomainARM-like

MON2 CAND2 MROH2A LTN1 ARFGEF2 CUL9 HEATR1 XPO7

2.96e-06270628IPR011989
DomainSpectrin/alpha-actinin

AKAP6 MCF2L2 DMD UTRN

3.69e-0632624IPR018159
DomainSPEC

AKAP6 MCF2L2 DMD UTRN

3.69e-0632624SM00150
DomainDystrophin

DMD UTRN

1.08e-052622IPR016344
DomainDUF1981

MON2 ARFGEF2

6.48e-054622PF09324
DomainSec7_N

MON2 ARFGEF2

6.48e-054622IPR032691
DomainSec7_N

MON2 ARFGEF2

6.48e-054622PF12783
DomainDCB_dom

MON2 ARFGEF2

6.48e-054622IPR032629
DomainDCB

MON2 ARFGEF2

6.48e-054622PF16213
DomainSec7_C

MON2 ARFGEF2

6.48e-054622IPR015403
DomainEF-hand_dom_typ1

DMD UTRN

1.61e-046622IPR015153
DomainEF-hand_dom_typ2

DMD UTRN

1.61e-046622IPR015154
DomainEF-hand_2

DMD UTRN

1.61e-046622PF09068
DomainEF-hand_3

DMD UTRN

1.61e-046622PF09069
Domain-

MON2 CAND2 ARFGEF2 CUL9 HEATR1

8.46e-042226251.25.10.10
DomainZZ

DMD UTRN

1.60e-0318622PF00569
DomainZF_ZZ_2

DMD UTRN

1.60e-0318622PS50135
DomainZF_ZZ_1

DMD UTRN

1.60e-0318622PS01357
DomainHEAT_REPEAT

CAND2 MROH2A HEATR1

1.63e-0370623PS50077
DomainZnf_ZZ

DMD UTRN

1.79e-0319622IPR000433
DomainZnF_ZZ

DMD UTRN

1.79e-0319622SM00291
DomainActinin_actin-bd_CS

DMD UTRN

2.62e-0323622IPR001589
DomainSpectrin

DMD UTRN

2.62e-0323622PF00435
DomainACTININ_2

DMD UTRN

2.62e-0323622PS00020
DomainACTININ_1

DMD UTRN

2.62e-0323622PS00019
DomainSpectrin_repeat

DMD UTRN

4.16e-0329622IPR002017
DomainCNMP_BINDING_1

CNGB1 KCNH3

5.04e-0332622PS00888
DomainCNMP_BINDING_2

CNGB1 KCNH3

5.04e-0332622PS00889
DomaincNMP

CNGB1 KCNH3

5.68e-0334622SM00100
DomaincNMP_binding

CNGB1 KCNH3

5.68e-0334622PF00027
DomaincNMP-bd_dom

CNGB1 KCNH3

6.01e-0335622IPR000595
DomainCNMP_BINDING_3

CNGB1 KCNH3

6.01e-0335622PS50042
DomaincNMP-bd-like

CNGB1 KCNH3

7.06e-0338622IPR018490
Pubmed

Comparative interactome analysis of α-arrestin families in human and Drosophila.

MON2 NUDT19 CAND2 ABR LTN1 CUL9 DMD UTRN SLC2A11

7.09e-0931365938270169
Pubmed

Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.

DMD UTRN

3.44e-06265210525423
Pubmed

Distribution of dystrophin- and utrophin-associated protein complexes during activation of human neutrophils.

DMD UTRN

3.44e-06265220434517
Pubmed

Enhanced currents through L-type calcium channels in cardiomyocytes disturb the electrophysiology of the dystrophic heart.

DMD UTRN

3.44e-06265224337461
Pubmed

Combined gene therapy via VEGF and mini-dystrophin synergistically improves pathologies in temporalis muscle of dystrophin/utrophin double knockout mice.

DMD UTRN

3.44e-06265233987645
Pubmed

Activation of calcineurin and stress activated protein kinase/p38-mitogen activated protein kinase in hearts of utrophin-dystrophin knockout mice.

DMD UTRN

3.44e-06265211297940
Pubmed

Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice.

DMD UTRN

3.44e-06265229408646
Pubmed

Plasma lipidomic analysis shows a disease progression signature in mdx mice.

DMD UTRN

3.44e-06265234155298
Pubmed

In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.

DMD UTRN

3.44e-06265228790199
Pubmed

Dystrophic changes in extraocular muscles after gamma irradiation in mdx:utrophin(+/-) mice.

DMD UTRN

3.44e-06265224466085
Pubmed

The Angiotensin Converting Enzyme Inhibitor Lisinopril Improves Muscle Histopathology but not Contractile Function in a Mouse Model of Duchenne Muscular Dystrophy.

DMD UTRN

3.44e-06265227110493
Pubmed

Rapid depletion of muscle progenitor cells in dystrophic mdx/utrophin-/- mice.

DMD UTRN

3.44e-06265224781208
Pubmed

Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.

DMD UTRN

3.44e-06265222388933
Pubmed

Isolation and characterization of a genomic clone from the murine utrophin locus.

DMD UTRN

3.44e-0626528268660
Pubmed

Metabolic dysfunction and altered mitochondrial dynamics in the utrophin-dystrophin deficient mouse model of duchenne muscular dystrophy.

DMD UTRN

3.44e-06265225859846
Pubmed

Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers.

DMD UTRN

3.44e-06265225642938
Pubmed

Activation of non-myogenic mesenchymal stem cells during the disease progression in dystrophic dystrophin/utrophin knockout mice.

DMD UTRN

3.44e-06265225859011
Pubmed

G-utrophin, the autosomal homologue of dystrophin Dp116, is expressed in sensory ganglia and brain.

DMD UTRN

3.44e-0626527731967
Pubmed

Satellite cells and utrophin are not directly correlated with the degree of skeletal muscle damage in mdx mice.

DMD UTRN

3.44e-06265215703201
Pubmed

Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.

DMD UTRN

3.44e-06265227037492
Pubmed

Microtubule binding distinguishes dystrophin from utrophin.

DMD UTRN

3.44e-06265224706788
Pubmed

Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non-muscle tissue.

DMD UTRN

3.44e-06265216710609
Pubmed

Improvement in survival and muscle function in an mdx/utrn(-/-) double mutant mouse using a human retinal dystrophin transgene.

DMD UTRN

3.44e-06265216487708
Pubmed

Utrophin suppresses low frequency oscillations and coupled gating of mechanosensitive ion channels in dystrophic skeletal muscle.

DMD UTRN

3.44e-06265225941878
Pubmed

Duchenne muscular dystrophy and the neuromuscular junction: the utrophin link.

DMD UTRN

3.44e-0626529297964
Pubmed

Nonclinical Exon Skipping Studies with 2'-O-Methyl Phosphorothioate Antisense Oligonucleotides in mdx and mdx-utrn-/- Mice Inspired by Clinical Trial Results.

DMD UTRN

3.44e-06265230672725
Pubmed

Voltage-gated ion channel dysfunction precedes cardiomyopathy development in the dystrophic heart.

DMD UTRN

3.44e-06265221677768
Pubmed

Dystrophin and utrophin do not play crucial roles in nonmuscle tissues in mice.

DMD UTRN

3.44e-06265210204788
Pubmed

SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models.

DMD UTRN

3.44e-06265225652448
Pubmed

Utrophin Compensates dystrophin Loss during Mouse Spermatogenesis.

DMD UTRN

3.44e-06265228785010
Pubmed

The role of proteases in excitation-contraction coupling failure in muscular dystrophy.

DMD UTRN

3.44e-06265225298424
Pubmed

Talin, vinculin and DRP (utrophin) concentrations are increased at mdx myotendinous junctions following onset of necrosis.

DMD UTRN

3.44e-0626527962191
Pubmed

Consequences of the combined deficiency in dystrophin and utrophin on the mechanical properties and myosin composition of some limb and respiratory muscles of the mouse.

DMD UTRN

3.44e-0626529713852
Pubmed

Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.

DMD UTRN

3.44e-06265216307000
Pubmed

Expression of the dystrophin isoform Dp116 preserves functional muscle mass and extends lifespan without preventing dystrophy in severely dystrophic mice.

DMD UTRN

3.44e-06265221949353
Pubmed

Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.

DMD UTRN

3.44e-06265225607927
Pubmed

Does utrophin expression in muscles of mdx mice during postnatal development functionally compensate for dystrophin deficiency?

DMD UTRN

3.44e-0626528021701
Pubmed

Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities.

DMD UTRN

3.44e-06265223097179
Pubmed

Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.

DMD UTRN

3.44e-06265226974331
Pubmed

rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice.

DMD UTRN

3.44e-06265216819550
Pubmed

Developmental studies of dystrophin-positive fibers in mdx, and DRP localization.

DMD UTRN

3.44e-0626528433092
Pubmed

The role of utrophin and Dp71 for assembly of different dystrophin-associated protein complexes (DPCs) in the choroid plexus and microvasculature of the brain.

DMD UTRN

3.44e-06265215501597
Pubmed

Second-generation compound for the modulation of utrophin in the therapy of DMD.

DMD UTRN

3.44e-06265225935002
Pubmed

Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice.

DMD UTRN

3.44e-06265216024571
Pubmed

Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.

DMD UTRN

3.44e-06265211257121
Pubmed

Characterization of dystrophin and utrophin diversity in the mouse.

DMD UTRN

3.44e-06265210072426
Pubmed

The sparing of extraocular muscle in dystrophinopathy is lost in mice lacking utrophin and dystrophin.

DMD UTRN

3.44e-0626529625743
Pubmed

Androgen receptor agonists increase lean mass, improve cardiopulmonary functions and extend survival in preclinical models of Duchenne muscular dystrophy.

DMD UTRN

3.44e-06265228453658
Pubmed

A quantitative study of bioenergetics in skeletal muscle lacking utrophin and dystrophin.

DMD UTRN

3.44e-06265211801396
Pubmed

Apo-dystrophin-1 and apo-dystrophin-2, products of the Duchenne muscular dystrophy locus: expression during mouse embryogenesis and in cultured cell lines.

DMD UTRN

3.44e-0626527987307
Pubmed

Utility of dystrophin and utrophin staining in childhood muscular dystrophy.

DMD UTRN

3.44e-06265216295426
Pubmed

Comparative analysis of the human dystrophin and utrophin gene structures.

DMD UTRN

3.44e-06265211861579
Pubmed

Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice.

DMD UTRN

3.44e-06265218973234
Pubmed

Distinct mechanical properties in homologous spectrin-like repeats of utrophin.

DMD UTRN

3.44e-06265230914715
Pubmed

Dystrophin is a microtubule-associated protein.

DMD UTRN

3.44e-06265219651889
Pubmed

Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice.

DMD UTRN

3.44e-0626529590295
Pubmed

Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains.

DMD UTRN

3.44e-06265222284942
Pubmed

Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice.

DMD UTRN

3.44e-06265229879154
Pubmed

Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice.

DMD UTRN

3.44e-06265217889902
Pubmed

Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy.

DMD UTRN

3.44e-06265212387876
Pubmed

Identification of Dp71 isoforms in the platelet membrane cytoskeleton. Potential role in thrombin-mediated platelet adhesion.

DMD UTRN

3.44e-06265212370193
Pubmed

Renin-angiotensin-aldosterone system inhibitors improve membrane stability and change gene-expression profiles in dystrophic skeletal muscles.

DMD UTRN

3.44e-06265227881412
Pubmed

Longitudinal metabolomic analysis of plasma enables modeling disease progression in Duchenne muscular dystrophy mouse models.

DMD UTRN

3.44e-06265232025735
Pubmed

Lifelong quercetin enrichment and cardioprotection in Mdx/Utrn+/- mice.

DMD UTRN

3.44e-06265227836895
Pubmed

Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies.

DMD UTRN

3.44e-06265220625423
Pubmed

Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle.

DMD UTRN

3.44e-06265229065908
Pubmed

Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy.

DMD UTRN

3.44e-06265231039133
Pubmed

Developmentally regulated expression and localization of dystrophin and utrophin in the human fetal brain.

DMD UTRN

3.44e-06265211796130
Pubmed

BGP-15 Improves Aspects of the Dystrophic Pathology in mdx and dko Mice with Differing Efficacies in Heart and Skeletal Muscle.

DMD UTRN

3.44e-06265227750047
Pubmed

Dystrophin and dystrophin-related protein in the brains of normal and mdx mice.

DMD UTRN

3.44e-0626528159184
Pubmed

Dystrophin and utrophin: genetic analyses of their role in skeletal muscle.

DMD UTRN

3.44e-06265210679963
Pubmed

TAT-μUtrophin mitigates the pathophysiology of dystrophin and utrophin double-knockout mice.

DMD UTRN

3.44e-06265221565990
Pubmed

Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin/utrophin expression.

DMD UTRN

3.44e-06265217967782
Pubmed

Generation and characterization of transgenic mice with the full-length human DMD gene.

DMD UTRN

3.44e-06265218083704
Pubmed

Expression of the dystrophin-related protein (utrophin) gene during mouse embryogenesis.

DMD UTRN

3.44e-0626528130373
Pubmed

Diaphragm rescue alone prevents heart dysfunction in dystrophic mice.

DMD UTRN

3.44e-06265221062902
Pubmed

Matricellular Protein CCN5 Gene Transfer Ameliorates Cardiac and Skeletal Dysfunction in mdx/utrn (±) Haploinsufficient Mice by Reducing Fibrosis and Upregulating Utrophin Expression.

DMD UTRN

3.44e-06265235557546
Pubmed

Characterization of the Ang/Tie2 Signaling Pathway in the Diaphragm Muscle of DMD Mice.

DMD UTRN

3.44e-06265237626761
Pubmed

Early Inflammation in Muscular Dystrophy Differs between Limb and Respiratory Muscles and Increases with Dystrophic Severity.

DMD UTRN

3.44e-06265233497702
Pubmed

Dystrophin and dystrophin-related protein (utrophin) distribution in normal and dystrophin-deficient skeletal muscles.

DMD UTRN

3.44e-0626528186702
Pubmed

ANG1 treatment reduces muscle pathology and prevents a decline in perfusion in DMD mice.

DMD UTRN

3.44e-06265228334037
Pubmed

Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy.

DMD UTRN

3.44e-06265225940966
Pubmed

Cardiomyopathic features associated with muscular dystrophy are independent of dystrophin absence in cardiovasculature.

DMD UTRN

3.44e-06265212868498
Pubmed

Molecular heterogeneity of the dystrophin-associated protein complex in the mouse kidney nephron: differential alterations in the absence of utrophin and dystrophin.

DMD UTRN

3.44e-06265215565469
Pubmed

Cardiac dysfunction and pathology in the dystrophin and utrophin-deficient mouse during development of dilated cardiomyopathy.

DMD UTRN

3.44e-06265222266080
Pubmed

Postnatal overexpression of the CT GalNAc transferase inhibits muscular dystrophy in mdx mice without altering muscle growth or neuromuscular development: evidence for a utrophin-independent mechanism.

DMD UTRN

3.44e-06265217300937
Pubmed

Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice.

DMD UTRN

3.44e-06265221768542
Pubmed

The N- and C-Terminal Domains Differentially Contribute to the Structure and Function of Dystrophin and Utrophin Tandem Calponin-Homology Domains.

DMD UTRN

3.44e-06265226516677
Pubmed

Social stress is lethal in the mdx model of Duchenne muscular dystrophy.

DMD UTRN

3.44e-06265232192914
Pubmed

Disease course in mdx:utrophin+/- mice: comparison of three mouse models of Duchenne muscular dystrophy.

DMD UTRN

3.44e-06265225921779
Pubmed

Assessment of cardiac function in three mouse dystrophinopathies by magnetic resonance imaging.

DMD UTRN

3.44e-06265222209498
Pubmed

α2 and α3 helices of dystrophin R16 and R17 frame a microdomain in the α1 helix of dystrophin R17 for neuronal NOS binding.

DMD UTRN

3.44e-06265223185009
Pubmed

Metabolic remodeling of dystrophic skeletal muscle reveals biological roles for dystrophin and utrophin in adaptation and plasticity.

DMD UTRN

3.44e-06265233359740
Pubmed

A Protocol for Simultaneous In Vivo Imaging of Cardiac and Neuroinflammation in Dystrophin-Deficient MDX Mice Using [18F]FEPPA PET.

DMD UTRN

3.44e-06265237108685
Pubmed

Gene expression effects of glucocorticoid and mineralocorticoid receptor agonists and antagonists on normal human skeletal muscle.

DMD UTRN

3.44e-06265228432191
Pubmed

Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.

DMD UTRN

3.44e-06265210694796
Pubmed

Dystrophin and dystrophin-related protein in the central nervous system of normal controls and Duchenne muscular dystrophy.

DMD UTRN

3.44e-0626528171962
Pubmed

Utrophin regulates modal gating of mechanosensitive ion channels in dystrophic skeletal muscle.

DMD UTRN

3.44e-06265224879867
Pubmed

Similar efficacy from specific and non-specific mineralocorticoid receptor antagonist treatment of muscular dystrophy mice.

DMD UTRN

3.44e-06265227822449
Pubmed

Endogenous bioluminescent reporters reveal a sustained increase in utrophin gene expression upon EZH2 and ERK1/2 inhibition.

DMD UTRN

3.44e-06265236966198
InteractionNPTN interactions

MON2 CAND2 LTN1 ARFGEF2 ACAD10 HEATR1 TSPYL1 INTS8 DOP1B XPO7

1.21e-082786210int:NPTN
InteractionGPR182 interactions

MON2 CAND2 ADCK1 LTN1 ARFGEF2 ACAD10 HEATR1 INTS8 QSOX2 DOP1B XPO7

1.24e-074556211int:GPR182
InteractionOPALIN interactions

MON2 CAND2 LTN1 ARFGEF2 HEATR1 INTS8 DOP1B XPO7

2.45e-07209628int:OPALIN
InteractionNPY2R interactions

MON2 CAND2 ADCK1 LTN1 ACAD10

1.81e-0666625int:NPY2R
InteractionCD244 interactions

CAND2 LTN1 ARFGEF2 HEATR1

9.16e-0643624int:CD244
InteractionP2RY10 interactions

MON2 CAND2 LTN1 ACAD10 HEATR1

1.87e-05106625int:P2RY10
InteractionHCST interactions

DENND6A ADCK1 LTN1 ACAD10 INTS8 XPO7

3.94e-05205626int:HCST
InteractionBCL2L14 interactions

NUDT19 CAND2 LTN1 ELP1 HEATR1

4.46e-05127625int:BCL2L14
InteractionMLNR interactions

CAND2 ADCK1 ACAD10 HEATR1

5.71e-0568624int:MLNR
InteractionMFSD4A interactions

MON2 ARFGEF2 ACAD10 HEATR1 DOP1B XPO7

6.61e-05225626int:MFSD4A
InteractionUPK2 interactions

MON2 LIME1 ARFGEF2 HEATR1 INTS8

7.58e-05142625int:UPK2
InteractionHLA-B interactions

MON2 LTN1 ARFGEF2 HEATR1 INTS8 DOP1B

9.22e-05239626int:HLA-B
InteractionCD40 interactions

MON2 JAK3 LTN1 ARFGEF2 HEATR1

1.08e-04153625int:CD40
InteractionTMEM108 interactions

CAND2 ACAD10 XPO7

1.17e-0431623int:TMEM108
InteractionVASN interactions

MON2 SF3A1 LTN1 ARFGEF2 XPO7

1.33e-04160625int:VASN
InteractionMAS1 interactions

DENND6A SELENBP1 ACAD10 XPO7

1.43e-0486624int:MAS1
InteractionVSIG4 interactions

MON2 DENND6A ARFGEF2 HEATR1 INTS8

2.30e-04180625int:VSIG4
InteractionGPR17 interactions

CAND2 ADCK1 LTN1 ARFGEF2 HEATR1 XPO7

2.31e-04283626int:GPR17
GeneFamilyZinc fingers ZZ-type|Lysine acetyltransferases

DMD UTRN

9.44e-041846291
GeneFamilyGuanylate cyclase receptors|DENN/MADD domain containing

DENND6A DENND1C

1.83e-0325462504
GeneFamilyZinc fingers MYND-type|A-kinase anchoring proteins

AKAP6 ARFGEF2

2.46e-0329462396
ToppCell5'-Adult-Appendix-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

JAK3 LIME1 AFF3 PVRIG CD79B DENND1C

4.22e-071966563f065139f76ed048875cd6c03aa02300db2b6574
ToppCellCOPD-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class

JAK3 DENND6A CD79B UTRN SFMBT2

8.57e-06190655ed978cd5d9da87b49878a330e362762c487f849f
ToppCell10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

BPTF AFF3 CD79B UTRN DOP1B

8.79e-06191655a073d58154c801ec499fd969f42b7f1ee7f15d79
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

AKAP6 AFF3 DGKG DMD UTRN

9.48e-061946555c3b2b05d1e4f146551fe4c920263d8e6ca34de3
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

AKAP6 AFF3 DGKG DMD UTRN

9.48e-06194655ab9cad697f9209d2889bc02b43b502dfeb2ebfef
ToppCellMild/Remission-B_naive-8|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)

BPTF AFF3 CD79B UTRN DOP1B

9.72e-061956550a3221e4d1fa31a35868bdda0f0cc873c233b407
ToppCell10x5'v1-week_14-16-Lymphocytic_B-B_lineage-immature_B_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

AFF3 CD79B DMD UTRN RASAL1

9.72e-06195655ecaaa3d071e763c40d05d088fbf9e8ca06f78f47
ToppCellControl_saline-Epithelial_alveolar-AT_1-AT1|Control_saline / Treatment groups by lineage, cell group, cell type

SELENBP1 ACAD10 RS1 UTRN SLC2A11

1.05e-051986559f972f217d2c39d4c0f7d0d4227d0fffe8535b9d
ToppCellTracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations

MON2 AFF3 DMD HERC1 UTRN

1.07e-0519965594b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell367C-Lymphocytic-CD4_T-cell-Treg_cell_2|367C / Donor, Lineage, Cell class and subclass (all cells)

TBC1D4 MCF2L2 CUL9 CD79B

8.19e-05157654f1c6c313836352271033d23efd31b0f0a8a09e02
ToppCellAdult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor

AKAP6 DGKG DMD PPEF2

8.39e-051586548d64c0c9de910a3f4658778642d183c8b9b6f6a2
ToppCell10x5'-Lung-Lymphocytic_T_CD4-Tregs|Lung / Manually curated celltypes from each tissue

LIME1 TBC1D4 RASAL1 PDE11A

8.39e-05158654f433bc189f000efa34e8e09ab32b3fa22bcf64c4
ToppCellIIF-Lymphocyte-T_NK-ILC|IIF / Disease, Lineage and Cell Type

B3GNT7 FER1L5 CNGB1 DNAH1

8.60e-0515965455e4f21548f480ca414c00cbff5ec3b13bafd271
ToppCelldroplet-Liver-LIVER-NPC-1m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AFF3 CD79B B3GNT7 DENND1C

9.46e-0516365466ecd544d7b52e61880b125bf39d1f406af6900a
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TBC1D4 CUL9 CD79B DENND1C

1.06e-04168654187b98664843a304406f086ea696adbf32283d07
ToppCellLPS-IL1RA-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

AFF3 PVRIG CD79B QSOX2

1.11e-0417065492e0873f618b2fa60c4d555b10f234d5cbcf3325
ToppCellLPS-IL1RA-Lymphocytic_B-B_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

AFF3 PVRIG CD79B QSOX2

1.11e-04170654c181991f933b779f99afc3782f292306f209e2ac
ToppCellLPS-IL1RA-Lymphocytic_B|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

AFF3 PVRIG CD79B QSOX2

1.11e-0417065456284fbfd1e53f67c8c0b7fba64505a4002adba2
ToppCelldroplet-Lung-nan-21m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBC1D4 AEBP2 PPEF2 KCNH3

1.14e-04171654159ce6d5513008532dd7785b915b3fe7440cc4b2
ToppCellMild/Remission-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

AFF3 CD79B UTRN DOP1B

1.19e-04173654694d02c4d2dc2de4b344544f9124fec40fcf7d8f
ToppCellLPS-antiTNF-Lymphocytic_B|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

AFF3 PVRIG CD79B QSOX2

1.22e-04174654cc493654ea3517bc6a145c7f787f304929636f86
ToppCellLPS-antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

AFF3 PVRIG CD79B QSOX2

1.22e-041746549eb3504f9340517ef5d056503044fbdb9ffeb714
ToppCellLPS-antiTNF-Lymphocytic_B-B_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

AFF3 PVRIG CD79B QSOX2

1.22e-04174654b4c2d1c029fcd0d4926aa79a5b789c713919dcf3
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

AKAP6 AFF3 DGKG DMD

1.24e-04175654d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

AKAP6 AFF3 DGKG DMD

1.24e-04175654454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0
ToppCellLPS_only-Lymphocytic_B-B_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

AFF3 PVRIG CD79B QSOX2

1.30e-04177654c82332c5f656aa26513e4f7525d5d4d733019725
ToppCellCOVID-19_Moderate-B_intermediate|COVID-19_Moderate / disease group, cell group and cell class

OR51B5 AFF3 CD79B DMD

1.30e-0417765468e3d12a0c048a2d0f1b9680c7338a35855bba30
ToppCellLPS_only-Lymphocytic_B|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

AFF3 PVRIG CD79B QSOX2

1.30e-041776545ed65e08d773d157840317c72e0d43c261d438d4
ToppCellLPS_only-Lymphocytic_B-B_cells-B-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

AFF3 PVRIG CD79B QSOX2

1.30e-041776548a955a7ab84c434f9ad4b467246b8be3cb479406
ToppCell5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

AFF3 MCF2L2 CBX7 B3GNT7

1.33e-041786540b59e3d75b143bd7bf91a7800a49699c51e68c5a
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

AKAP6 KCNH3 CFAP46 DNAH1

1.33e-041786543b12db04006db6e94fc45649a4b3a63b92f21a61
ToppCellnormal_Pleural_Fluid-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass

AFF3 SLC2A11 RASAL1 KCNH3

1.42e-04181654cc7ae1221a28bc404138a7efee0ad08a19cc3d86
ToppCellwk_20-22-Hematologic-Meg-ery-Definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

SELENBP1 HERC1 QSOX2 XPO7

1.45e-041826540c77ef4556c1d1512ebe9077df858b28f9e38dd5
ToppCell356C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

AURKA TBC1D4 SF3A1 MCF2L2

1.48e-04183654f142b320023eef00b48d4820c46214c9794d37e7
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MROH2A DMD UNC79 DNAH1

1.51e-041846542cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MROH2A DMD UNC79 DNAH1

1.51e-04184654ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MROH2A DMD UNC79 DNAH1

1.51e-041846542b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellLV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper

AKAP6 TBC1D4 DGKG DMD

1.51e-04184654ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

AFF3 DGKG DMD UTRN

1.54e-0418565451dfe6ac7df8b330343b37e3bee71e5c65267189
ToppCellLV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper

AKAP6 TBC1D4 DGKG DMD

1.54e-041856546baccb26f999145e51b91d94315bf8d4655bef31
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

AFF3 DGKG DMD UTRN

1.54e-04185654a8c02cec3c414f3a0da9f2d6d28ce563b0030705
ToppCellImmune-B_cell|World / Lineage, Cell type, age group and donor

AFF3 CD79B QSOX2 RASAL1

1.60e-04187654795690c6306c366e733279491138d0cd9b469b21
ToppCellSmart-seq2-spleen_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

AFF3 CD79B B3GNT7 UTRN

1.67e-04189654b0244a9d1b5c8ad4708750b691184f3491b13900
ToppCellRV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper

AKAP6 TBC1D4 DGKG DMD

1.67e-041896545e80c47f63980904c4c1ff02c201b67b456a0974
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

AKAP6 AFF3 DGKG DMD

1.67e-04189654127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ToppCellFetal_29-31_weeks-Immune-enucleated_erythrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

SELENBP1 HERC1 QSOX2 XPO7

1.67e-041896541900e574870fc647bfa11c732a72f3d38aab717c
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

AKAP6 AFF3 DGKG DMD

1.67e-041896542cfb4d12f75678d1619f4743838a0e954bd57761
ToppCellLV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper

AKAP6 TBC1D4 DGKG DMD

1.71e-04190654de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCellILEUM-non-inflamed-(1)_T_cell-(1)_Tregs|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

TBC1D4 MCF2L2 CUL9 CD79B

1.71e-04190654f69a4733b5d1542ab4d0eb44856f2c5c34c18b9e
ToppCellFetal_29-31_weeks-Immune-B_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

AFF3 CD79B QSOX2 RASAL1

1.71e-04190654424550418c1bd4eb070cf3c41cf09fa9d89aef37
ToppCellRV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper

AKAP6 TBC1D4 DGKG DMD

1.71e-04190654fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCellLV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper

AKAP6 TBC1D4 DGKG DMD

1.74e-0419165425f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCellFetal_29-31_weeks-Immune-B_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

AFF3 CD79B QSOX2 RASAL1

1.74e-0419165484452125d1b5b76974e3f9126f611eff16d45c25
ToppCellCD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster

MON2 ARFGEF2 HEATR1 DOP1B

1.74e-041916549454f642c3621370fa23640b631301346b300950
ToppCellASK454-Epithelial-Secretory|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq

ELP1 CD79B SFMBT2 DOP1B

1.74e-04191654c63c781e7e93265e591cf494cb4ce8ed797c24fb
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

AKAP6 AFF3 DGKG DMD

1.78e-04192654bfab13793e54de2550ee171397f7ece0625cdb4a
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

ZNF852 B3GNT7 KCNH3 CFAP46

1.78e-04192654a22952b885c8a7704a4a9602fa03e4f2c786bf75
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

ZNF852 B3GNT7 KCNH3 CFAP46

1.78e-04192654dcf2d0c2e8868104c4dba410456207f0d947029a
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

AKAP6 AFF3 DGKG DMD

1.78e-04192654b54b0d5b88139905521c8d5d58332e89c08d589c
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

JAK3 LIME1 TBC1D4 CD79B

1.81e-041936547deb439943d35a4e825674b2b7dcddb45d366ad1
ToppCellsevere-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

MCF2L2 CBX7 HERC1 UTRN

1.81e-041936549337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

AFF3 CD79B DMD QSOX2

1.85e-04194654e9c907b8ec4329946338cca5ce8e954fa2cec37b
ToppCelldistal-Hematologic-Myeloid_Dendritic_Type_1-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

TBC1D4 MCF2L2 SFMBT2 RASAL1

1.85e-04194654f0467d81063a9b19783906c456935ef8318b9b98
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

AFF3 DGKG DMD UTRN

1.85e-04194654ebb038f94f49f5c655578d1b018676e10c6b7e3c
ToppCellCOVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type

AKAP6 TBC1D4 DGKG DMD

1.88e-04195654f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCellCOVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type

AKAP6 TBC1D4 DGKG DMD

1.88e-0419565475fc81bddb246dca3b437fb60827b1d4fe416405
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

AFF3 DGKG DMD UTRN

1.92e-04196654b8759e6231e0254797d6c30930407b79440c57bb
ToppCellTracheal-NucSeq-Immune_Lymphocytic-B-B_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

JAK3 AFF3 PVRIG CD79B

2.00e-04198654824461cf44098440ba8bc0df96735423ac65bda1
ToppCellmild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

MON2 BPTF HERC1 UTRN

2.04e-04199654f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCellLPS_IL1RA_TNF-Epithelial_alveolar|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

SELENBP1 ACAD10 UTRN SLC2A11

2.08e-04200654c89f3cb36bb14c476d6a392bfd3ded1c8feecfeb
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

AKAP6 ABR DGKG DMD

2.08e-04200654c06426f877919bdd267ea2fd7e7973c6619832ae
ToppCellControl_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3|Control_saline / Treatment groups by lineage, cell group, cell type

AKAP6 ABR DGKG DMD

2.08e-04200654b0866b497aa71d06cef25f9a335fa584e95fa7e0
Diseaseattention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement

AKAP6 BPTF AFF3 ELP1 HERC1 UTRN UNC79 PDE11A

2.95e-04801638EFO_0003888, EFO_0007052, MONDO_0002491
DiseaseParoxysmal atrial fibrillation

AKAP6 CAND2 HERC1 XPO7

3.51e-04156634C0235480
DiseasePersistent atrial fibrillation

AKAP6 CAND2 HERC1 XPO7

3.51e-04156634C2585653
Diseasefamilial atrial fibrillation

AKAP6 CAND2 HERC1 XPO7

3.51e-04156634C3468561
DiseaseAtrial Fibrillation

AKAP6 CAND2 HERC1 XPO7

3.87e-04160634C0004238
DiseaseHypermetropia, Myopia

AKAP6 BPTF MCF2L2 PDE11A

7.23e-04189634HP_0000540, HP_0000545
Diseasefetal hemoglobin measurement

OR51B5 OR51B6

9.18e-0421632EFO_0004576
Diseasemuscular dystrophy (implicated_via_orthology)

DMD UTRN

9.18e-0421632DOID:9884 (implicated_via_orthology)
Diseaseatrial fibrillation

AKAP6 CAND2 ACAD10 HERC1 XPO7

1.18e-03371635EFO_0000275
Diseasevital capacity

CAND2 AFF3 ARFGEF2 CD79B B3GNT7 UTRN QSOX2 KCNH3 PDE11A

1.19e-031236639EFO_0004312
DiseaseMalignant neoplasm of breast

AKAP6 AURKA MCF2L2 ARFGEF2 ELP1 DGKG DMD ZNF546

1.97e-031074638C0006142
Diseaseloneliness measurement

BPTF ARFGEF2 UTRN

2.39e-03124633EFO_0007865
DiseaseDuchenne muscular dystrophy (implicated_via_orthology)

DMD UTRN

2.70e-0336632DOID:11723 (implicated_via_orthology)
Diseaseblood molybdenum measurement

AKAP6 ACAD10

3.00e-0338632EFO_0007582
Diseasesmoking status measurement

MON2 BPTF AFF3 HERC1 UTRN UNC79 KCNH3 PDE11A

3.17e-031160638EFO_0006527
DiseaseColorectal Carcinoma

AKAP6 AURKA SELENBP1 SF3A1 MCF2L2 DMD

3.82e-03702636C0009402
Diseaseglioblastoma (is_marker_for)

CBX7 HEATR1

4.01e-0344632DOID:3068 (is_marker_for)
Diseaseinterleukin 17 measurement

ADCK1 UTRN

4.19e-0345632EFO_0008174

Protein segments in the cluster

PeptideGeneStartEntry
MEPLSHRGLPRLSWI

ABR

1

Q12979
CVEEIIREMTWLPPL

AFF3

301

P51826
PRIHWDLSTERVLLM

ADCK1

256

Q86TW2
KLLLHWMPEDILPDV

AEBP2

446

Q6ZN18
RPMLREVLEHPWITA

AURKA

371

O14965
TIPHVLLTWRPVGME

ARFGEF2

1481

Q9Y6D5
HLRWAVEILLAMKPP

CFAP46

1241

Q8IYW2
TIPAMERLIEWLPLH

ACAD10

436

Q6JQN1
VLPPLMEWIRVAVAH

BTBD11

501

A6QL63
RLEPQSMVWLPVLHR

DMD

3286

P11532
ALLYPMRWEHVLIPT

DENND1C

236

Q8IV53
VMLPIWRESLGHTRL

BPTF

961

Q12830
LSPVPSHWMVALLLL

CD79B

6

P40259
RFPHWDEVLELREMP

RASAL1

176

O95294
MLQEWLASLPLDRIP

QSOX2

376

Q6ZRP7
DPWRIRQILIELHGM

INTS8

521

Q75QN2
PAVLSLEMLTDRIPW

JAK3

676

P52333
LALPWDPHSLEMVLI

KCNH3

1051

Q9ULD8
LPMQWLHRPLLEGRL

LTN1

961

O94822
WLPIILLTADGMVHL

NUDT19

291

A8MXV4
LRISPQHLTSLWPIM

DOP1B

2081

Q9Y3R5
MELLHSLLPQGPDRW

HERC1

861

Q15751
RLLPAEPRLHMEWIR

KIAA1614

581

Q5VZ46
ITPMDFIWLKHLIPD

MCF2L2

646

Q86YR7
MPTVLGVLWLDHREI

OR51B5

76

Q9H339
MPTVLGVLWLDHREI

OR51B6

76

Q9H340
PRLQLEWIDSICMPL

PDE11A

866

Q9HCR9
IVSLMWDPVTPYRLH

ELP1

346

O95163
MHRIEILWRPLTGHL

MON2

806

Q7Z3U7
LITVWADPRLHARPM

OR10G3

46

Q8NGC4
LQEMQLPLILEPWCH

PRSS38

201

A1L453
PLVMLDRWHLEVIPR

DGKG

551

P49619
PSWMPALERLIEHIN

DNAH1

3736

Q9P2D7
LADWRIRPLPEEMLS

EXOSC10

421

Q01780
EPLPDHLVLLMWSLI

SLC2A11

56

Q9BYW1
TWEPEEHILDPRLVM

CBX7

41

O95931
HSQMLWELVLLGEPL

DENND6A

281

Q8IWF6
RLLDFPEAMVLPWHE

CUL9

1021

Q8IWT3
RMLIPYIEHWPRALS

COQ9

191

O75208
YIEHWPRALSILMLP

COQ9

196

O75208
SEWHIELMLDRGIPV

HEATR1

751

Q9H583
LVVHKLLPPELLAMW

B3GNT7

371

Q8NFL0
QELVRALWPLHRPRM

CAND2

546

O75155
IRELPLLNAMPLHSW

PIWIL3

496

Q7Z3Z3
AVESVLHLGLPWRML

PPEF2

596

O14830
ITLIWIDPRLHTPMY

OR5G3

46

P0C626
PLPMESHLAEVWLAV

MROH2A

1166

A6NES4
PQSMVWLPVLHRVAA

UTRN

3046

P46939
DLQDRILPPMRWHPL

FER1L5

1176

A0AVI2
WLLPEMPGLITDILL

SELENBP1

301

Q13228
QEHMRIGLLDPRWLE

SF3A1

426

Q15459
RLHSPPEVTNMLWEL

PLA2G3

406

Q9NZ20
IVLHLPEIETWLRMT

AKAP6

66

Q13023
VAWVLHRLEMALPQP

CNGB1

256

Q14028
LWPEPLGVEHFLREM

URGCP

606

Q8TCY9
WPLHEALRMDPLEAI

TSPYL1

221

Q9H0U9
WKPAELEPMERILEH

ZNF75CP

161

Q92670
RLMWLHLEGLQTPVP

SFMBT2

436

Q5VUG0
PLHSLSIMPRFLWIL

ZNF546

21

Q86UE3
RLIHILMWTTNLEPL

PRAMEF10

326

O60809
LDHRTTLPMLPWLMA

TBC1D4

46

O60343
ELMLERSPQVWLGHL

ZNF852

516

Q6ZMS4
MPILQRAIELWYHDP

XPO7

751

Q9UIA9
LIPLGWHVRIAIRME

RS1

201

O15537
MGHRTLVLPWVLLTL

PVRIG

21

Q6DKI7
LLWLHVLSELDIMVP

UNC79

686

Q9P2D8
LRPASMDLLRPHWLE

LIME1

91

Q9H400